Estrogen Receptor Positive Breast Cancer Completed Phase 2 Trials for Sapanisertib (DB11836)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02988986TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast CancerTreatment